UBS AM’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.03M | Buy |
276,955
+10,406
| +4% | +$201K | ﹤0.01% | 1475 |
|
|
2025
Q4 | $5.74M | Buy |
266,549
+33,088
| +14% | +$697K | ﹤0.01% | 1388 |
|
|
2025
Q3 | $4.5M | Sell |
233,461
-162,706
| -41% | -$2.9M | ﹤0.01% | 1420 |
|
|
2025
Q2 | $6.77M | Sell |
396,167
-67,175
| -14% | -$2.87M | ﹤0.01% | 1551 |
|
|
2025
Q1 | $29.6M | Buy |
463,342
+164,041
| +55% | +$17.3M | 0.01% | 810 |
|
|
2024
Q4 | $36.4M | Buy |
299,301
+31,098
| +12% | +$3.81M | 0.01% | 740 |
|
|
2024
Q3 | $33.5M | Sell |
268,203
-33,278
| -11% | -$4.6M | 0.01% | 774 |
|
|
2024
Q2 | $47.6M | Buy |
301,481
+140,454
| +87% | +$18M | 0.01% | 625 |
|
|
2024
Q1 | $20.8M | Buy |
161,027
+15
| +0% | +$1.84K | 0.01% | 783 |
|
|
2023
Q4 | $15.5M | Sell |
161,012
-170
| -0.1% | -$16.3K | 0.01% | 840 |
|
|
2023
Q3 | $19.5M | Buy |
161,182
+4,493
| +3% | +$508K | 0.01% | 766 |
|
|
2023
Q2 | $21.6M | Hold |
156,689
| – | – | 0.01% | 747 |
|
|
2023
Q1 | $21.6M | Buy |
156,689
+35,368
| +29% | +$4.59M | 0.01% | 747 |
|
|
2022
Q4 | $15.7M | Buy |
121,321
+1,254
| +1% | +$145K | 0.01% | 810 |
|
|
2022
Q3 | $13.3M | Sell |
120,067
-18,440
| -13% | -$1.86M | 0.01% | 871 |
|
|
2022
Q2 | $10.4M | Buy |
138,507
+962
| +0.7% | +$70.8K | 0.01% | 944 |
|
|
2022
Q1 | $10.7M | Sell |
137,545
-27,201
| -17% | -$2.08M | ﹤0.01% | 1044 |
|
|
2021
Q4 | $14.8M | Buy |
164,746
+62,655
| +61% | +$5.36M | 0.01% | 985 |
|
|
2021
Q3 | $9.44M | Sell |
102,091
-9,632
| -9% | -$742K | ﹤0.01% | 1115 |
|
|
2021
Q2 | $8.69M | Sell |
111,723
-93,319
| -46% | -$7.07M | ﹤0.01% | 1170 |
|
|
2021
Q1 | $15.3M | Sell |
205,042
-201,513
| -50% | -$18.6M | 0.01% | 944 |
|
|
2020
Q4 | $69.3M | Buy |
406,555
+10,676
| +3% | +$1.58M | 0.03% | 496 |
|
|
2020
Q3 | $55.6M | Buy |
395,879
+340
| +0.1% | +$51.7K | 0.03% | 486 |
|
|
2020
Q2 | $63.4M | Sell |
395,539
-60,320
| -13% | -$8.21M | 0.04% | 429 |
|
|
2020
Q1 | $44.6M | Buy |
455,859
+4,386
| +1% | +$501K | 0.03% | 473 |
|
|
2019
Q4 | $58.3M | Buy |
451,473
+58,372
| +15% | +$5.89M | 0.04% | 486 |
|
|
2019
Q3 | $29.6M | Buy |
393,101
+96,536
| +33% | +$11.4M | 0.02% | 665 |
|
|
2019
Q2 | $45.1M | Buy |
296,565
+42,263
| +17% | +$5.14M | 0.03% | 560 |
|
|
2019
Q1 | $30.3M | Buy |
254,302
+9,919
| +4% | +$1.28M | 0.02% | 641 |
|
|
2018
Q4 | $26.7M | Buy |
244,383
+21,262
| +10% | +$2.66M | 0.02% | 635 |
|
|
2018
Q3 | $36M | Buy |
+223,121
| New | +$30.5M | 0.03% | 603 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
